Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide.

Mar Drugs · 2022 · PMC9410082 · PMID 36005503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The reduction in non-HDL cholesterol in overweight participants on the 2 g dose also showed a trend to reduction in the atherogenic index (log(triglycerides/HDL-cholesterol)).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.